•  
  •  
  •  
  •  

2025-12-23 13:49:22

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  ArchidplyIndustries

Stock Report

  • Archidply Industries Ltd consolidated Q1 FY26 profit up at Rs. 56.81 lakhs
  • Archidply Industries Ltd's subsidiary resumes operations at MDF plant
  • Archidply Industries Ltd Q3FY24 consolidated PAT drops to Rs. 1.46 crore
  • Archidply Industries Ltd Q1 FY2024 PAT at Rs. 2.30 crore
  • Archidply Industries Ltd Q4 FY23 consolidated net profit up QoQ at Rs. 2.56 crore
  • Archidply Industries Ltd Q3 FY2023 PAT lower at Rs. 2.22 crore
  • Archidply Industries Ltd Q2FY23 net profit at Rs. 2.99 crores
  • Archidply Industries Q4FY22 PAT climbs to Rs. 2.90 crore
  • Archidply Industries Q3 FY2021-22 profit lower at Rs. 2.44 crores
  • Archidply Industries Ltd reports profit of Rs. 2.67 crore in Q2FY22

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024